Wang, A-L
Elman, I
Lowen, S B
Blady, S J
Lynch, K G
Hyatt, J M
O'Brien, C P
Langleben, D D
Article History
Received: 5 June 2014
Revised: 12 January 2015
Accepted: 12 January 2015
First Online: 17 March 2015
Competing interests
: CPO'B served as a consultant to Alkermes plc and Tekmira Pharmaceuticals. The remaining authors declare no conflicts of interest.